Biotech entity
pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Environmental Protection Agency, the most common co-covered peer. We currently track 1 Biotech story that mention AdvaMed, all published on March 13, 2026.
Last mentioned: Mar 13, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Environmental Protection Agency, the most common co-covered peer. We currently track 1 Biotech story that mention AdvaMed, all published on March 13, 2026. Each carries 3 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering AdvaMed. Shared-story counts are live from our verified record — not editorial picks.
The Environmental Protection Agency (EPA) has moved to ease pollution restrictions on ethylene oxide (EtO), a critical chemical used to sterilize half of all U.S. medical devices. This regulatory shift aims to prevent potential healthcare supply chain disruptions but faces immediate backlash from environmental and public health advocates.
AdvaMed is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
